Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Proteins differentially expressed by Shiga toxin-producing Escherichia coli strain M03 due to the biliar salt sodium deoxycholate.

Ribeiro CB, Sobral MG, Tanaka CL, Dallagassa CB, Picheth G, Rego FG, Alberton D, Huergo LF, Pedrosa FO, Souza EM, Fadel-Picheth CM.

Genet Mol Res. 2013 Oct 24;12(4):4909-17. doi: 10.4238/2013.October.24.1.

2.

Immunoproteomic analysis to identify Shiga toxin-producing Escherichia coli outer membrane proteins expressed during human infection.

Montero D, Orellana P, Gutiérrez D, Araya D, Salazar JC, Prado V, Oñate A, Del Canto F, Vidal R.

Infect Immun. 2014 Nov;82(11):4767-77. doi: 10.1128/IAI.02030-14. Epub 2014 Aug 25.

3.

Therapeutic strategies for Shiga toxin-producing Escherichia coli infections.

Rogers TJ, Paton JC.

Expert Rev Anti Infect Ther. 2009 Aug;7(6):683-6. doi: 10.1586/eri.09.51.

PMID:
19681694
4.

Phylogenetic and molecular analysis of food-borne shiga toxin-producing Escherichia coli.

Hauser E, Mellmann A, Semmler T, Stoeber H, Wieler LH, Karch H, Kuebler N, Fruth A, Harmsen D, Weniger T, Tietze E, Schmidt H.

Appl Environ Microbiol. 2013 Apr;79(8):2731-40. doi: 10.1128/AEM.03552-12. Epub 2013 Feb 15.

5.

Top-down proteomic identification of Shiga toxin 2 subtypes from Shiga toxin-producing Escherichia coli by matrix-assisted laser desorption ionization-tandem time of flight mass spectrometry.

Fagerquist CK, Zaragoza WJ, Sultan O, Woo N, Quiñones B, Cooley MB, Mandrell RE.

Appl Environ Microbiol. 2014 May;80(9):2928-40. doi: 10.1128/AEM.04058-13. Epub 2014 Feb 28.

6.

Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study.

Bielaszewska M, Mellmann A, Zhang W, Köck R, Fruth A, Bauwens A, Peters G, Karch H.

Lancet Infect Dis. 2011 Sep;11(9):671-6. doi: 10.1016/S1473-3099(11)70165-7. Epub 2011 Jun 22.

PMID:
21703928
7.

Relationship between pathogenicity for humans and stx genotype in Shiga toxin-producing Escherichia coli serotype O157.

Kawano K, Okada M, Haga T, Maeda K, Goto Y.

Eur J Clin Microbiol Infect Dis. 2008 Mar;27(3):227-32. Epub 2007 Dec 11.

PMID:
18071766
8.

Hemolytic uremic syndrome in a 65-Year-old male linked to a very unusual type of stx2e- and eae-harboring O51:H49 shiga toxin-producing Escherichia coli.

Fasel D, Mellmann A, Cernela N, Hächler H, Fruth A, Khanna N, Egli A, Beckmann C, Hirsch HH, Goldenberger D, Stephan R.

J Clin Microbiol. 2014 Apr;52(4):1301-3. doi: 10.1128/JCM.03459-13. Epub 2014 Feb 5.

9.

Neonatal hemolytic uremic syndrome after mother-to-child transmission of a low-pathogenic stx2b harboring shiga toxin-producing Escherichia coli.

Stritt A, Tschumi S, Kottanattu L, Bucher BS, Steinmann M, von Steiger N, Stephan R, Hächler H, Simonetti GD.

Clin Infect Dis. 2013 Jan;56(1):114-6. doi: 10.1093/cid/cis851. Epub 2012 Oct 5.

10.

The dilemma of antimicrobial treatment of Shiga toxin-producing Escherichia coli.

Mor M, Ashkenazi S.

Pediatr Infect Dis J. 2014 Sep;33(9):979-81. doi: 10.1097/INF.0000000000000425. Review. No abstract available.

PMID:
25361025
11.

Shiga toxin, cytolethal distending toxin, and hemolysin repertoires in clinical Escherichia coli O91 isolates.

Bielaszewska M, Stoewe F, Fruth A, Zhang W, Prager R, Brockmeyer J, Mellmann A, Karch H, Friedrich AW.

J Clin Microbiol. 2009 Jul;47(7):2061-6. doi: 10.1128/JCM.00201-09. Epub 2009 Apr 29.

12.

Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.

Müthing J, Schweppe CH, Karch H, Friedrich AW.

Thromb Haemost. 2009 Feb;101(2):252-64. Review.

PMID:
19190807
13.

Serotype, Shiga toxin (Stx) type, and antimicrobial resistance of Stx-producing Escherichia coli isolated from humans in Shizuoka Prefecture, Japan (2003-2007).

Hiroi M, Takahashi N, Harada T, Kawamori F, Iida N, Kanda T, Sugiyama K, Ohashi N, Hara-Kudo Y, Masuda T.

Jpn J Infect Dis. 2012;65(3):198-202.

14.

Virulence profile comparison between LEE-negative Shiga toxin-producing Escherichia coli (STEC) strains isolated from cattle and humans.

Galli L, Miliwebsky E, Irino K, Leotta G, Rivas M.

Vet Microbiol. 2010 Jul 14;143(2-4):307-13. doi: 10.1016/j.vetmic.2009.11.028. Epub 2009 Nov 27.

PMID:
20022185
15.

Effects of ampicillin, gentamicin, and cefotaxime on the release of Shiga toxins from Shiga toxin-producing Escherichia coli isolated during a diarrhea episode in Faisalabad, Pakistan.

Mohsin M, Haque A, Ali A, Sarwar Y, Bashir S, Tariq A, Afzal A, Iftikhar T, Saeed MA.

Foodborne Pathog Dis. 2010 Jan;7(1):85-90. doi: 10.1089/fpd.2009.0311.

PMID:
19785532
16.

The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome.

Orth D, Grif K, Khan AB, Naim A, Dierich MP, Würzner R.

Diagn Microbiol Infect Dis. 2007 Nov;59(3):235-42. Epub 2007 Oct 10.

PMID:
17931818
17.

Impact of antibiotics on the intestinal microbiota and on the treatment of Shiga-toxin-producing Escherichia coli and Salmonella infections.

Szych J, Wołkowicz T, La Ragione R, Madajczak G.

Curr Pharm Des. 2014;20(28):4535-48. Review.

PMID:
24180404
18.

First detection of Shiga toxin-producing Escherichia coli in shellfish and coastal environments of Morocco.

Bennani M, Badri S, Baibai T, Oubrim N, Hassar M, Cohen N, Amarouch H.

Appl Biochem Biotechnol. 2011 Sep;165(1):290-9. doi: 10.1007/s12010-011-9251-x. Epub 2011 Apr 21.

PMID:
21509602
19.

Shiga toxin-producing Escherichia coli strains negative for locus of enterocyte effacement.

Newton HJ, Sloan J, Bulach DM, Seemann T, Allison CC, Tauschek M, Robins-Browne RM, Paton JC, Whittam TS, Paton AW, Hartland EL.

Emerg Infect Dis. 2009 Mar;15(3):372-80. doi: 10.3201/eid1503.080631.

20.

Effect of environmental conditions on proteins secreted by enterohemorrhagic Escherichia coli O26:H11.

Yoh M, Bi Z, Matsuyama J, Nagayama K, Honda T.

Microbiol Immunol. 2003;47(1):1-6.

Supplemental Content

Support Center